Unit Of Li Ka-Shing’s CK Life Sciences To Merge With Nasdaq-Listed Biotech Company In $100 Million Deal

CK Life Sciences’ WEX Pharmaceuticals is combining with Virios Therapeutics to tap into the U.S. capital market.